Global Diabetes Software Market Growth (Status and Outlook) 2023-2029

Global Diabetes Software Market Growth (Status and Outlook) 2023-2029

Diabetes software can include aggregate and analytical views of diabetes data. These views include:

– Calendar views that display glucose trends and compare them to patient’s insulin intake.

– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.

– Listing of contextual and lifestyle data such as patient’s carb intake.

– Insulin data that includes pie charts showing the ratio of basal to bolus rates.

– General data tables that show average blood glucose rates bucketed into different time periods

– And more.

More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.

LPI (LP Information)' newest research report, the “Diabetes Software Industry Forecast” looks at past sales and reviews total world Diabetes Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetes Software sales for 2023 through 2029. With Diabetes Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Software industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Software market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Software.

The global Diabetes Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Diabetes Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Diabetes Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Diabetes Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Diabetes Software players cover Glooko, Accu-Chek (Roche), Tidepool, LifeScan, Inc (Platinum Equity), Pharmaco Diabetes, Ascensia Diabetes Care Holdings AG, Diabeto Medtech India Pvt. Ltd, Abbott Diabetes Care and Acon Diabetes Care International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Software market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
For Smartphones
For Tablet PC
Web-based

Segmentation by application
Type 1 Diabetes
Type 2 Diabetes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

Please note: The report will take approximately 2 business days to prepare and deliver.